Valeant to redeem 5 3/8%, 6 3/8%, 6¾%, 7¼% senior notes on July 2

By Wendy Van Sickle

Columbus, Ohio, June 1 – Valeant Pharmaceuticals International, Inc. said it will redeem one series of its notes and three series of notes issued by its Valeant Pharmaceuticals International subsidiary on July 2, according to a press release.

The notes include Valeant Pharmaceuticals International, Inc.’s $691 million 5 3/8% senior notes due 2020 and Valeant Pharmaceuticals International’s $146 million 6 3/8% senior notes due 2020, $578 million 6¾% senior notes due 2021 and $550 million 7¼% senior notes due 2022.

The redemptions will be funded using a portion of a new term loan and some proceeds of a new $750 million issue of 8.6-year 8½% senior notes, as well as cash on hand.

Bank of New York Mellon Trust Co., NA is the trustee.

The specialty pharmaceutical company is based in Laval, Quebec.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.